Home Biofeedback Therapy for Dyssynergic Defecation, Fecal Incontinence and Urinary Incontinence
Part of paid clinical trials in Augusta, Georgia.
- Sponsor
- Augusta University
- Study ID
- NCT05771597
- Status
- Recruiting
Conditions
- Dyssynergic Defecation
- Fecal Incontinence
- Urinary Incontinence
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Home Biofeedback therapy — OTHERPatients will be given home biofeedback device to take home and practice biofeedback exercises at least twice a day for six weeks of therapy. 1. HBT for patients with constipation and dyssynergic defecation: Patients will attend one session of training on how to use the device followed by daily sessions at home for 6 weeks. After placing a probe into rectum, the patient sits on a commode, activates the smart phone app and follow the voice-guided instructions to perform diaphragmatic breathing exercises and push maneuvers with/without balloon distension. 2. HBT for patients with FI: Subject will receive training on how to use the home-trainer device and probe placement. The patient will be asked to follow a series of voice guided instructions consisting of performing short and long duration squeeze maneuvers over 25 minutes. 3. HBT for patients with UI: The instructions protocol as written above for patients with FI will be followed for UI patients as well.
- Office biofeedback therapy — OTHERPatients will receive traditional office biofeedback, once weekly, over six weeks. 1. OBT for patients with constipation and dyssynergic defecation: The patient will receive instructions on the diaphragmatic breathing techniques. Then the patient sits on a commode, coordination between push effort and the anal and pelvic floor relaxation is corrected by the therapist. The patients will receive visual and verbal feedback instructions from the therapist. 2. OBT for patients with FI: Patients will be taught Kegels and abdominal muscle exercises. Visual and verbal feedback techniques are used to reinforce the maneuvers. The patient is instructed to squeeze and to maintain this squeeze for as long as possible. 3. OBT for patients with UI: Biofeedback training is performed using the protocol and objectives as described above for FI training.
Study Details
Biofeedback therapy is an effective treatment for the management of patients with dyssynergic defecation and constipation, urinary incontinence (UI), and fecal incontinence (FI). It is labor-intensive, costly, requires multiple office or hospital visits, is not easily available to the vast majority of patients in the community, and is not covered by many insurance companies. The purpose of this study is to 1. Evaluate home biofeedback therapy for patients with either constipation and dyssynergic defecation or urinary leakage or stool leakage by assessing the efficacy and safety of a wireless anorectal biofeedback device, and a cellphone app-based and voice guided home biofeedback training system 2. To compare the efficacy and safety of home biofeedback therapy system with the standard of care, office biofeedback therapy 3. To assess the cost-effectiveness of home biofeedback therapy.
Key Dates
- Start date
- Mar 27, 2023
- Status verified
- Mar 2023
- Primary completion
- Dec 31, 2025
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 72 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: Home Biofeedback Therapy (HBT)1. HBT for patients with constipation and dyssynergic defecation: 2. HBT for patients with FI 3. HBT for patients with UI All patients will be advised to practice HBT at least once or twice a day for six weeks.
- Active Comparator: Office Biofeedback Therapy (OBT)1. OBT for patients with constipation and dyssynergic defecation. 2. OBT for patients with FI. 3. OBT for patients with UI. All patients will receive office biofeedback, once weekly, over six weeks.
Primary Outcome Measure
The number of complete spontaneous bowel movements (CSBM) per week for patients with dyssynergic defecation [ Time Frame: 6 weeks (short term) ]
Central Contacts
- Satish Rao, MD, PhD706-721-2239
- Bianca Marsh, BS706-446-5765
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Augusta University | Augusta | Georgia | 30912 |
Find similar trials in Augusta, GA
Related Studies
- Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)Recruiting · The California Medical Innovations Institute, Inc. · San Diego, California
- Muscle Fiber Fragment Treatment for Urinary IncontinencePHASE1/PHASE2 · Recruiting · Wake Forest University · Winston-Salem, North Carolina
- Adjustable Continence Therapy (ACT) for the Treatment of Female SUIRecruiting · Uromedica · Denver, Colorado
- Indiana University Gastrointestinal Motility Diagnosis RegistryRecruiting · Indiana University · Indianapolis, Indiana